Mounjaro generated $8.66 billion (+125% YoY) and Zepbound delivered $4.16 billion (+80% YoY)
Scientists are looking into the possibility, so that in the future, we may see glutathione as a cure for AIDS and clinical depression (which I believe are two very major health concerns these days)
Key Insight: Discover how HSAs are migrating spend from providers to e-commerce and digital health platforms
Although the relative quiet since March might have suggested a shift in enforcement direction, the emerging pattern is that FDA conducts ongoing monitoring and then releases warning letters in coordinated batches rather than steadily over timemeaning quiet periods should not be read as reduced priority
*Correspondence: Byung-Wan Lee, [email protected] These authors have contributed equally to this work This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
